The Fraunhofer-Institute for Molecular Biology and Applied Ecology (IME) stands for innovative and applied research dedicated to people’s health and the environment. The Fraunhofer IME practices applied life sciences from molecule to ecosystem.
The Department for Immunotherapy (IMT) at the Fraunhofer IME in Aachen develops and tests antibody-based immunodiagnostics and therapeutics for infectious diseases, leukemia, and oncological diseases. Join our scientific team in a key position and be responsible for the research on monoclonal antibodies and recombinant proteins. You will work in a group on the identification, generation and production of custom-tailored immunoreagents with the potential for application in diagnosis or therapy of human or animal disease. You will isolate disease-specific relevant antibodies, perform complex protein engineering and purification as well as functionally characterize candidate molecules. Some of your work will involve handling of potentially infectious materials, cell cultures and viruses at biosafety level 2. You will develop new assays and enhance current methodologies. You will be responsible for data analysis, reporting and presentation of results including preparation for publication. The scientific project coordination with relevant partners and support in funding acquisition will also be part of your job as well as supervision and mentoring of PhD candidates, students or technicians, based on your knowledge and skills.
What we expect from you
- PhD degree (Dr. rer. nat. or equivalent) in a biosciences, biomedical or a related discipline
- Excellent knowledge in molecular biology and immunology
- Good practical experience in molecular biological methods and standard techniques in immunology
- Experiences in hybridoma technology, phage-display libraries, expression of recombinant proteins, genetic engineering, flow cytometry and/or single cell PCR would be desirable
- Competences in cell culture systems, protein purification, next generation sequencing and antibody engineering would be advantageous
- Previous experiences in rodent (mouse) animal models is an advantage
- Demonstrated ability to conduct independent research in a collaborative environment
- Enthusiasm to work in an interdisciplinary and multicultural team and to contribute your scientific ideas
- Critical and rational-analytical thinking, rigor in laboratory experimentation and data analysis
- Knowledge in German laws/regulations related to genetic engineering would be beneficial
- Track record of previous research achievements (e.g., publications)
- Competence to teach and supervise PhD candidates, students, and technicians
- Good command of English language and communication skills
What you can expect from us
- A diversified and challenging appointment in a stimulating interdisciplinary research environment at an internationally renowned research institute with a modern infrastructure
- Excellent training and educational opportunities
Appointment, remuneration and social security benefits based on the public-sector collective wage agreement (TVöD).
In case of identical qualifications, preference will be given to severely disabled candidates.
The Fraunhofer-Gesellschaft is committed to providing equal career opportunities for men and women.
The position is initially limited for two years.
Fraunhofer is Europe’s largest application-oriented research organization. Our research efforts are geared entirely to people’s needs: health, security, communication, energy and the environment. As a result, the work undertaken by our researchers and developers has a significant impact on people’s lives. We are creative. We shape technology. We design products. We improve methods and techniques. We open up new vistas.
Applications should be submitted in English or German. For environmental reasons we kindly ask you to only apply online, by pressing the "Apply"-button.
For further information please contact Dr. Joern Schmiz (firstname.lastname@example.org) or Dr. Rolf Fendel (email@example.com).
|Job Reference: IME-MB-2017-2||Closing Date: 19.02.2017|